| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 6114427 | Autoimmunity Reviews | 2016 | 6 Pages | 
Abstract
												Patients with mild signs of acute inflammation are usually treated with non-steroidal anti-inflammatory drugs and small doses of prednisone. Patients with severe manifestations, such as airway compromise may require high doses of prednisone or even intravenous pulse methyl-prednisone.
											Related Topics
												
													Life Sciences
													Immunology and Microbiology
													Immunology
												
											Authors
												Lucia Longo, Antonio Greco, Andrea Rea, Vincenza Rita Lo Vasco, Armando De Virgilio, Marco De Vincentiis, 
											